iSABR: Safety and efficacy results from a phase II study of SABR in combination with durvalumab for early-stage medically inoperable NSCLC Meeting Abstract
| Authors: | Lee, P.; Stube, A.; Felix, C.; Oseguera, D.; Romero, T.; Goldman, J.; Garon, E.; Lee, J. M.; Glaspy, J.; Lisberg, A. E.; Rusthoven, C. G. Jr; Camidge, D. R.; Siva, S.; Solomon, B.; Lee, A.; Tenn, S. E.; Shaverdian, N.; Steinberg, M. L.; Raldow, A. |
| Abstract Title: | iSABR: Safety and efficacy results from a phase II study of SABR in combination with durvalumab for early-stage medically inoperable NSCLC |
| Meeting Title: | 64th Annual Meeting of the American Society for Radiation Oncology (ASTRO 2022) |
| Journal Title: | International Journal of Radiation Oncology, Biology, Physics |
| Volume: | 114 |
| Issue: | 3 Suppl. |
| Meeting Dates: | 2022 Oct 23-26 |
| Meeting Location: | Virtual |
| ISSN: | 0360-3016 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2022-11-01 |
| Start Page: | S30 |
| Language: | English |
| DOI: | 10.1016/j.ijrobp.2022.07.384 |
| PROVIDER: | EBSCOhost |
| PROVIDER: | cinahl |
| DOI/URL: | |
| Notes: | Meeting Abstract: 146 -- In section "Oral Scientific Sessions" -- Source: Cinahl |
